APR 25, 2019 10:30 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar

Advances in Point-Of-Care Testing for Infectious Diseases

SPONSORED BY: Chembio
C.E. CREDITS: P.A.C.E. CE | Florida CE
Speakers
  • Global Marketing Director, Chembio Diagnostic Systems
    Biography
      Krishnan Allampallam joined Chembio Diagnostic Systems, Inc about two years and serves as Global Director of Marketing. Krishnan has spent over 15+ years in the biotechnology industry. Before beginning his career in biotech, Krishnan focused his research in the field of oncology and has authored and co-authored multiple publications, abstracts and book chapters in peer reviewed journals. He received his Ph.D. from University of Toledo Medical Center in 1996 and did post-doctoral research at The Cleveland Clinic and Rush University Medical Center. Currently Krishnan is the Global Director of Marketing at Chembio Diagnostics, a New York Based public company focused on point of care rapid diagnostics. Prior to Chembio, Krishnan held various leadership positions in marketing and global product management.
    • Vice President, Research & Development, Chembio Diagnostic Systems
      Biography
        Paul Lambotte joined Chembio Diagnostic Systems, Inc. in December 2014, and serves as Vice President of Product Development. Prior to joining the company, Mr. Lambotte was President of PLC Inc., a POC product development consulting company. He previously served as Chief Science Officer at Axxin Pty Ltd, held positions of VP of R&D and Business Development at Quidel Corporation, and held a number of positions at Beckman Coulter and Hybritech Inc. Mr. Lambotte is the inventor of several patents in the field of rapid, point-of-care diagnostic products. He received a Master in Biochemistry and a PhD in Protein Biochemistry from the University of Mons, Belgium, and did post-doctoral work at the Ludwig Institute for Cancer research in Brussels, Belgium.

      Abstract:

      Point-of-care testing (POCT) is diagnostic testing at the time and place of patient care in a physician’s office, an ambulance, a mobile clinic, at home or in hospital.  Rapid POC testing yields actionable results and rapid treatment of patients. Until now, POC tests based on lateral flow technology have suffered of limitations in sensitivity, specificity, the lack of multiplexing and the questionable reliability of results obtained visually by the users.  To address these limitations, Chembio has developed an advanced rapid POC testing solution, the DPP® System combining its Dual Path Platform (DPP®) disposable cartridges with its optical analyzer (DPP® Reader). The DPP® System provides users with a complete solution for rapid testing at the Point of Care. The DPP® System requires one small sample from the patient, minimum hands-on time, short turn-around time, and provides multiple results in one operation, free from human bias.  During the webinar “Advances in POC Testing for infectious diseases”, we will introduce the advanced DPP® technology, the optical analyzer, and demonstrate the power of the DPP® Systems in detecting multiple biomarkers at the Point of Care. 

      Learning Objectives: 

      1. Current needs and status of POC diagnostics in infectious diseases
      2. What is DPP technology and how it differs from the current lateral flow technology
      3. Application of DPP technology in multiplex testing
      4. How the combination of DPP technology and  a hand held digital reader in POC testing improves testing accuracy


      Show Resources
      You May Also Like
      MAY 16, 2019 04:00 PM CEST
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      C.E. CREDITS
      MAY 16, 2019 04:00 PM CEST
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      DATE: May 16, 2019TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST The emergence of NGS is revolutionizing the microbiological sciences and transforming medicine. Deep sequencing has...
      FEB 26, 2019 09:00 AM PST
      C.E. CREDITS
      FEB 26, 2019 09:00 AM PST
      DATE:  February 26, 2019TIME:   9:00am PST, 12:00pm EST In an era of increasingly high-throughput, large-scale biology, with companies, government and non-prof...
      MAR 05, 2019 09:00 AM PST
      C.E. CREDITS
      MAR 05, 2019 09:00 AM PST
      DATE:  March 5, 2019TIME:  09:00am PST, 12:00pm EST MicroRNA(miRNA) are short non-coding single stranded RNA molecules that regulate gene expression at the post tran...
      MAY 21, 2019 07:00 AM PDT
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      C.E. CREDITS
      MAY 21, 2019 07:00 AM PDT
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      DATE: May 21, 2019TIMEL 7:00am PT, 10:00am ET Human T cells are central effectors of immunity and cancer immunotherapy. CRISPR-based functional studies in T cells could prioriti...
      NOV 21, 2019 09:00 AM PST
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      C.E. CREDITS
      NOV 21, 2019 09:00 AM PST
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      DATE: November 21, 2019TIME: 9:00am PST, 12:00pm EST Multiple Myeloma is a disease of terminally differentiated plasma cells with the massive production of monoclonal immunoglobu...
      NOV 15, 2018 10:00 AM PST
      C.E. CREDITS
      NOV 15, 2018 10:00 AM PST
      DATE:  November 15, 2018TIME:  10:00am PT, 1:00pm ET Multiplex fluorescence immunohistochemistry offers a window into the biology of human disease, enabling the ana...
      Loading Comments...
      Show Resources
      Event Countdown
      • 0 Days
      • 0 Hours
      • 0 Minutes
      • 0 Seconds